Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
MP Materials
MP
$9.84B
| – | – |
-14,300
| Closed | -$252K |
|
3777
Morgan Stanley
MS
$338B
| – | – |
-757,783
| Closed | -$79M |
|
3778
MSCI
MSCI
$40.8B
| – | – |
-136,121
| Closed | -$79.3M |
|
3779
Match Group
MTCH
$8.45B
| – | – |
-482,764
| Closed | -$18.3M |
|
3780
Maris-Tech
MTEK
$12.5M
| – | – |
-92,750
| Closed | -$176K |
|
3781
Vail Resorts
MTN
$5.26B
| – | – |
-96,900
| Closed | -$16.9M |
|
3782
Minerals Technologies
MTX
$2.3B
| – | – |
-14,600
| Closed | -$1.13M |
|
3783
Direxion Daily Homebuilders & Supplies Bull 3X ETF
NAIL
$613M
| – | – |
-4,500
| Closed | -$761K |
|
|
FEED
3784
ENvue Medical Inc
FEED
$3.7M
| – | – |
-242
| Closed | -$16.3K |
|
3785
Nabors Industries
NBR
$1.3B
| – | – |
-4,725
| Closed | -$305K |
|
|
NCNA
3786
NuCana
NCNA
$5.99M
| – | – |
-84
| Closed | -$38.7K |
|
3787
Noble Corp
NE
$7.1B
| – | – |
-125,590
| Closed | -$4.54M |
|
3788
Nephros
NEPH
$46.4M
| – | – |
-24,444
| Closed | -$41.8K |
|
3789
Cloudflare
NET
$109B
| – | – |
-171,900
| Closed | -$13.9M |
|
3790
National Fuel Gas
NFG
$7.82B
| – | – |
-20,700
| Closed | -$1.25M |
|
3791
Neurogene
NGNE
$714M
| – | – |
-22,807
| Closed | -$957K |
|
3792
Nurix Therapeutics
NRIX
$2.69B
| – | – |
-246,400
| Closed | -$5.54M |
|
3793
Insperity
NSP
$1.94B
| – | – |
-68,700
| Closed | -$6.05M |
|
3794
Nutrien
NTR
$32.1B
| – | – |
-39,985
| Closed | -$1.92M |
|
3795
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.21B
| – | – |
-27,300
| Closed | -$1.36M |
|
3796
Nucor
NUE
$61.9B
| – | – |
-141,400
| Closed | -$21.3M |
|
3797
Nuvectis Pharma
NVCT
$632M
| – | – |
-15,800
| Closed | -$99.4K |
|
|
NVEE
3798
DELISTED
NV5 Global
NVEE
| – | – |
-164,340
| Closed | -$3.84M |
|
3799
Enviri
NVRI
$566M
| – | – |
-65,200
| Closed | -$674K |
|
3800
nVent Electric
NVT
$27.1B
| – | – |
-115,300
| Closed | -$8.1M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.